News
-
-
-
COMMUNIQUÉ DE PRESSE
CoTec Holdings Corp. Files Third Quarter 2024 Results with Continued Focus on Its Operational Roll-Out
CoTec Holdings Corp. announces unaudited financial statements for Q3 2024 and highlights positive progress on various projects, including Lac Jeannine Iron Tailings Project and HyProMag USA feasibility study -
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Mynaric secures USD 11 million bridge loan and expects to agree on an up to USD 9 million production increase incentive agreement to meet immediate working capital needs
Mynaric AG secures USD 11 million bridge loan and plans up to USD 9 million production increase incentive agreement to address working capital needs -
COMMUNIQUÉ DE PRESSE
Gladstone Investment Announces Retirement of Chief Operating Officer Terry Lee Brubaker
Gladstone Investment Corporation announces retirement of COO Terry Lee Brubaker. Michael LiCalsi to take on additional responsibilities. National search for Chief Investment Officer initiated -
-
COMMUNIQUÉ DE PRESSE
Gladstone Commercial Corporation Announces Retirement of Chief Operating Officer Terry Lee Brubaker
Gladstone Commercial Corporation announces retirement of Chief Operating Officer Terry Lee Brubaker. Michael LiCalsi to take on additional responsibilities. Company conducting search for new Chief Investment Officer -
-
COMMUNIQUÉ DE PRESSE
New to the Street to Showcase Innovators in Electric Vehicles, Water Solutions, Environmental Conservation, and Cybersecurity on Fox Business: Episode 612 Airs Monday, November 18 at 10:30 PM PST
New to The Street announces Episode 612 featuring exclusive interviews with leaders in electric vehicles, sustainable water solutions, environmental conservation, and secure communications airing on Fox Business. Insights on technology, sustainability, and cybersecurity -
COMMUNIQUÉ DE PRESSE
Inventiva will present data from the final analysis of the Phase 2 study evaluating the combination of lanifibranor with empagliflozin in patients with MASH and T2D at the AASLD The Liver Meeting® late-breaker session
Inventiva presents positive results from Phase 2 study on lanifibranor and empagliflozin combination therapy for MASH and T2D patients at AASLD The Liver Meeting® 2024
